Caduet NDC 0069-6180

NDC codes

FDA NDC Directory

Product NDC (as listed)0069-6180Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00069-6180Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0069-6180-30	00069618030	30 TABLET, FILM COATED in 1 BOTTLE (0069-6180-30)Marketed from Aug 31, 2022

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Caduet
Generic name (nonproprietary): amlodipine and atorvastatin
Active ingredients: Amlodipine besylate — 5 mg/1Atorvastatin calcium trihydrate — 10 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Pfizer Laboratories Div Pfizer Inc
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021540
Marketing start: Aug 31, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Dihydropyridines (Chemical structure)Hydroxymethylglutaryl-CoA Reductase Inhibitors (Mechanism)
Identifiers: Product ID 0069-6180_7df1ff98-e490-4df8-8631-b21dc94a396eSPL ID 7df1ff98-e490-4df8-8631-b21dc94a396eSPL set ID 6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6RxCUI 404011, 404013, 597967, 597977, 597980, 597984, 597987, 597990, 750199, 750203, 750207, 750211, 750227, 750231, 750235, 750239UNII 864V2Q084H, 48A5M73Z4QUPC 0300692150305, 0300692250302, 0300692170303, 0300692160304, 0300692190301, 0300696565303, 0300696747303, 0300697810303, 0300692270300, 0300697232303, 0300697476301, 0300696180308, 0300696323309, 0300692260301, 0300697654303
Pharmacologic class: Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker; HMG-CoA Reductase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400069618030 followed by a unit qualifier and the quantity

Package 00069-6180-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 25, 2026.

Indications (excerpt from the label)

CADUET (amlodipine and atorvastatin) is indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate. CADUET is a combination of amlodipine besylate, a calcium channel blocker, and atorvastatin calcium, a HMG-CoA-reductase inhibitor (statin), indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate ( 1 ). Amlodipine is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. Amlodipine is indicated for the treatment of Coronary Artery Disease ( 1 ). Atorvastatin is indicated ( 1 …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)